Drug
Alphanate SD HT
Alphanate SD HT: highest development phase Post-Market, developed by Grifols. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alphanate SD/HT NCT00323856 | Post-Market | Severe Hemophilia A |
| Alphanate SD/HT NCT00555555 | Post-Market | Von Willebrand Disease |
Latest
No recent events.
Follow Alphanate SD HT on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.